International Journal of Obesity

Solera Health Expands its Curated Network to Help Payers and Employers Address High-Cost Cardiometabolic Disease

Retrieved on:

Tuesday, April 16, 2024

Mortality, Genetics, International Journal of Obesity, Diabetes, Weight loss, Obesity, Solera, Patient, Movement, Hypertension, Cardiovascular disease, Longevity, Anxiety, Sleep, HALO, Disease, Pharmaceutical industry

The additional solutions enable payers and employers to address high-cost conditions associated with cardiometabolic health – integrating several proven, industry-leading digital health partners.

Key Points:

The additional solutions enable payers and employers to address high-cost conditions associated with cardiometabolic health – integrating several proven, industry-leading digital health partners.
New solutions enhance Solera’s ability to impact hypertension, high cholesterol, diabetes prevention and weight management – and include Ciba Health, Digbi Health and Wondr Health.
Diabetes and cardiovascular disease are among the most expensive and prevalent diseases in the U.S., affecting over 121 million Americans.
"Cardiometabolic conditions remain a leading cause of preventable morbidity and mortality while accounting for over 30% of healthcare costs in the United States alone,” said Dr. Byron Crowe, Chief Medical Officer at Solera Health.

Addressing Obesity in the Public Sector

Retrieved on:

Thursday, February 22, 2024

PHD, Diabetes, Anxiety, International Journal of Obesity, Obesity, Weight loss, Public sector, Health, MPH, Movement, Nursing

Dallas, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Employee retention, well-being, and productivity are more important than ever for public sector organizations who face persistent staffing shortages.

Key Points:

Dallas, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Employee retention, well-being, and productivity are more important than ever for public sector organizations who face persistent staffing shortages.
Leading obesity expert Tim Church, MD, MPH, PHD, will join Wellness Benefits Program Specialist and Wondr Health client Grace Aspiras from Virginia Beach City Public Schools to discuss opportunities public sector employers have when it comes to disease prevention, obesity management, and strategies to address the unique needs of this population.
The webinar, “Obesity in the public sector: An affordable approach to sustainable weight loss,” will take place from 2 – 2:30 p.m. CT on Thursday, Feb. 29, 2024.
To learn more about how Wondr helped Virginia Beach City Public schools, register for the webinar.

Optum Rx Offers New Weight Management Program

Retrieved on:

Tuesday, December 12, 2023

Optum Rx, a pharmacy care services company, has launched Optum Rx Weight Engage, a comprehensive weight management and wellness support program.

Key Points:

Optum Rx, a pharmacy care services company, has launched Optum Rx Weight Engage, a comprehensive weight management and wellness support program.
Optum Rx Weight Engage will be available to consumers of plan sponsors, including employers, beginning Jan. 1, 2024.
Optum Rx Weight Engage is designed to support employers, health plans and the consumers for whom they provide benefits with a comprehensive approach to drive better health outcomes and manage coverages.
“Optum Rx Weight Engage offers clinically appropriate programs that support wellness and better health for consumers and solutions to help clients manage drug spending,” said Dr. Patrick Conway, CEO, Optum Rx.

Welldoc Receives 11th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar®

Retrieved on:

Wednesday, August 23, 2023

This clearance immediately follows Welldoc’s 10th 510(k) clearance announcement earlier this month, solidifying the company’s continued leadership in chronic care innovation.

Key Points:

This clearance immediately follows Welldoc’s 10th 510(k) clearance announcement earlier this month, solidifying the company’s continued leadership in chronic care innovation.
This feature enhances BlueStar’s existing digital coaching capabilities, which guide dietary and lifestyle decisions and assist individuals in self-managing their diabetes.
Welldoc is the first company to receive clearance for a CGM-informed bolus calculator specifically designed for adults who manage their diabetes with multiple daily injections of insulin.
“This 11th 510(k) clearance is a remarkable achievement for Welldoc and demonstrates our steadfast commitment to transforming chronic care.

Guilt-Free Peanut Pleasures

Retrieved on:

Tuesday, June 27, 2023

ALBANY, Ga. , June 27, 2023 /PRNewswire/ -- A summer indulgence that's guilt-free and packed with nutrition is possible. It all starts with a base of peanut butter or peanuts since just one serving of this mighty superfood delivers protein, fiber, healthy fats and 19 vitamins and minerals.

Key Points:

In a food processor, blend together a 24-ounce container of full-fat cottage cheese, ½ cup peanut butter and ¼ cup plus two tablespoons maple syrup until smooth.
Stir in four chopped peanut butter cups and three tablespoons chopped peanuts.
Based in Albany, Ga., The Peanut Institute is a non-profit organization supporting nutrition research and developing educational programs to encourage healthful lifestyles that include peanuts and peanut products.
Consumption of peanut products improves memory and stress response in healthy adults from the ARISTOTLE study: A 6-month randomized controlled trial.

Herbalife Nutrition's Expertise and Leadership in Nutrition Will Be Featured at Upcoming Global Scientific and Wellness Conferences in the First Quarter

Retrieved on:

Monday, February 6, 2023

In addition to being the premier sponsor of the symposium, the Company will present the results from the second phase of research.

Key Points:

In addition to being the premier sponsor of the symposium, the Company will present the results from the second phase of research.
Zheng Qunyi, Ph.D., Chairman of the Herbalife Group, China, will give a keynote speech on Herbalife Nutrition’s product innovations, and the development of China’s nutrition industry.
Additionally, Denise Cervantes, CPT-ASM, CPT-NASM, Specialist, Sports Performance and Fitness Education at Herbalife Nutrition taught a fitness class to the attendees.
Carolina Chevallier, RD, MS, senior manager, Scientific Affairs for Herbalife Nutrition, Latin America, will support module 2 with a presentation titled, "Efficacy of bioactive food compounds."

New Research in Over 3,700 Patients Treated With World’s First and Only Swallowable Gastric Balloon Program Reveals Weight Loss of Over 14% Total Body Weight

Retrieved on:

Wednesday, November 2, 2022

A study conducted in 3,716 patients from 26 centers across 9 countries treated with the Allurion swallowable gastric balloon and lifestyle program revealed an average Total Body Weight Loss (TBWL) of 14.1% after just four months.

Key Points:

A study conducted in 3,716 patients from 26 centers across 9 countries treated with the Allurion swallowable gastric balloon and lifestyle program revealed an average Total Body Weight Loss (TBWL) of 14.1% after just four months.
This study provides further evidence to support the broader metabolic benefits of the Allurion Program.
A previous study in 226 patients with Type 2 diabetes and prediabetes demonstrated that on average, the Allurion Program brought both diseases into remissionii.
These results underscore the benefits of the Allurion Program beyond weight loss and highlight how quickly the Allurion Program can have a significant health impact on patients.

Getlabs Partners with JumpstartMD to Provide In-Home Phlebotomy Services

Retrieved on:

Tuesday, September 27, 2022

Through research-based, medically supervised programs, JumpstartMD offers nutritional science and one-on-one support to change lives.

Key Points:

Through research-based, medically supervised programs, JumpstartMD offers nutritional science and one-on-one support to change lives.
"By empowering JumpstartMD members with convenient at-home blood draw services, we can help increase program adherence."
JumpstartMD provides recommendations for real food, individualized support from its team of experts, and a scientifically proven approach, which emphasizes health improvements that are easily tracked through Getlabs' in-home phlebotomy service.
JumpstartMD provides services including Weight Loss, Bioidentical Hormone Replacement Therapy, Vitamin Therapy and Supplement Therapy.

New Study Determines That in the Past 20 Years Obesity in America Increased by 40% and Severe Obesity Almost Doubled

Retrieved on:

Wednesday, August 31, 2022

TAMPA, Fla., Aug. 31, 2022 /PRNewswire/ -- Recently released statistics from a new study detail the problem of obesity in the United States and its continued rise. The findings published in the Journal of Obesity looked at the long-term weight gain of almost 14,000 adults in the U.S. and they revealed some startling conclusions.1

Key Points:

TAMPA, Fla., Aug. 31, 2022 /PRNewswire/ --Recently released statistics from a new study detail the problem of obesity in the United States and its continued rise.
On average, Americans gain 17 pounds between the ages of 20 and 39 and an average of 45 pounds during their lifetime.
"In roughly 20 years, the prevalence of obesity increased by approximately 40% and severe obesity almost doubled," said Larry Tucker, a Professor of Exercise Science at Brigham Young University in Provo, Utah.
The iScale from Smart Meter is an easy way for a person and their provider to track weight in real time.

Overweight Treatment Market estimated to surge ahead at a CAGR of 7.9% by the end of 2032 - Persistence Market Research

Retrieved on:

Monday, June 6, 2022

Per capita healthcare spending is on the rise, which is predicted to fuel the demand for high-quality patient care treatment alternatives.

Key Points:

Per capita healthcare spending is on the rise, which is predicted to fuel the demand for high-quality patient care treatment alternatives.
Developing economies such as Brazil, India, and Russia are expected to contribute significantly to the anti-obesity drug development industry.
By distribution channel, institutional sales are gaining higher traction for overweight treatment, and held a market value share of 58.2% in 2021.
"High incidence of morbid obesity and rising efforts to mitigate indications associated with overweight are driving sales in the overweight treatment market," says an analyst of Persistence Market Research.